Skip to main navigation Skip to search Skip to main content

Assessing the in vitro anti-dengue virus activity of molnupiravir

Project: Research

Project Details

StatusFinished
Effective start/end date10/13/21 → 10/12/25

Funding

  • Merck Sharp and Dohme Limited Liability Corporation: $20,915.10